NCT06241846 2025-08-27A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPCMediLink Therapeutics (Suzhou) Co., Ltd.Phase 2 Recruiting100 enrolled